In August, Pfizer halted production of its single-dose vial version of naloxone because of a manufacturing issue it’s been working with the FDA to solve.
Drug experts estimate the shortage will mean about 1 million fewer naloxone doses, which could lead to as many as 18,000 avoidable overdose deaths.
Pfizer expects the shortage to continue through February, according to the report.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
